Zhang G, Gao M, Xu D, Olivier NB, Mukkamala R. Pulse arrival time is not an adequate surrogate for pulse transit time as a marker of blood pressure. J Appl Physiol 111: 1681-1686. First published September 29, 2011 doi:10.1152/japplphysiol.00980.2011.-Pulse transit time (PTT) is a proven, simple to measure, marker of blood pressure (BP) that could potentially permit continuous, noninvasive, and cuff-less BP monitoring (after an initial calibration). However, pulse arrival time (PAT), which is equal to the sum of PTT and the pre-ejection period, is gaining popularity for BP tracking, because it is even simpler to measure. The aim of this study was to evaluate the hypothesis that PAT is an adequate surrogate for PTT as a marker of BP. PAT and PTT were estimated through the aorta using high-fidelity invasive arterial waveforms obtained from six dogs during wide BP changes induced by multiple interventions. These time delays and their reciprocals were evaluated in terms of their ability to predict diastolic, mean, and systolic BP (DBP, MBP, and SBP) per animal. The root mean squared error (RMSE) between the BP parameter predicted via the time delay and the measured BP parameter was specifically used as the evaluation metric. Taking the reciprocals of the time delays tended to reduce the RMSE values. The DBP, MBP, and SBP RMSE values for 1/PAT were 9.8 Ϯ 5.2, 10.4 Ϯ 5.6, and 11.9 Ϯ 6.1 mmHg, whereas the corresponding values for 1/PTT were 5.3 Ϯ 1.2, 4.8 Ϯ 1.0, and 7.5 Ϯ 2.2 mmHg (P Ͻ 0.05). Thus tracking BP via PAT was not only markedly worse than via PTT but also unable to meet the FDA BP error limits. In contrast to previous studies, our results quantitatively indicate that PAT is not an adequate surrogate for PTT in terms of detecting challenging BP changes.
THE TIGHT RELATIONSHIP BETWEEN pulse transit time (PTT) and blood pressure (BP) has long been known (2, 3) . The physiological mechanisms responsible for this relationship are well understood. PTT decreases as the arterial elastic modulus increases according to the Moens-Korteweg equation (17, 22) . The arterial elastic modulus, in turn, increases as BP increases, because collagen fibers are slack and do not apply tension until the arterial wall is stretched. While changes in vasomotor tone can also modulate the arterial elastic modulus, this effect is less of a factor in the aorta wherein smooth muscle is relatively sparse (4) .
PTT can be estimated simply as the foot-to-foot time delay between proximal and distal arterial waveforms. Thus PTT could conceivably permit continuous, noninvasive, and cuffless BP monitoring in the acute setting (after an initial calibration). Indeed, many researchers have pursued PTT as a marker of BP (22) . Thomas (27) proposed to make the measurement process even simpler by instead using the time delay between the R-wave of an ECG waveform and the distal arterial waveform foot. This pulse arrival time (PAT) has captured great interest recently (1, 6, 11, 12, 14, 28) . PAT is equal to the sum of PTT and the pre-ejection period (PEP). However, PEP, which is determined by the ventricular electromechanical delay and isovolumic contraction phase, can vary with contractility and afterload while often constituting a nontrivial fraction of PTT (9, 15, 21, 23, 29) . Thus, PAT, on the contrary, may not be an adequate surrogate for PTT as a marker of BP.
To our knowledge, only a few researchers have compared PAT to PTT in terms of their ability to predict BP. Steptoe et al. (25) studied humans and concluded that PAT could be used in lieu of PTT; however, for ethical reasons, the elicited BP range was too narrow to provide a significant challenge. Ochiai et al. (19) examined animals during several different hemodynamic interventions and drew a similar conclusion; however, the comparisons were made over just a single intervention at a time and were therefore likewise less challenging. Geddes et al. (8) investigated animals over a wide BP range and concluded that PAT could not be used in place of PTT; however, only a qualitative result from one subject was provided to justify this conclusion. Payne et al. (20) recently performed a complex study in humans and concluded that PAT was an unreliable marker of BP; however, PTT was similarly ineffective perhaps due to artifact in the noninvasive arterial waveforms that were measured. Thus continued efforts are needed to determine whether PAT may be used as a surrogate for PTT as a marker of BP or not.
In this study, we compared PAT and PTT in terms of their ability to predict BP in animals. Notable aspects of the study include 1) estimating PAT and PTT through the aorta from high fidelity, invasive arterial waveforms; 2) inducing a wide BP range via a broad array of hemodynamic interventions; 3) evaluating PAT and PTT across multiple interventions at a time; and 4) providing quantitative results from all subjects. A preliminary version of this study has been reported in abbreviated form (31) .
MATERIALS AND METHODS

Experimental Data
We studied experimental data collected from six anesthetized dogs under a protocol approved by the MSU All-University Committee on Animal Use and Care. The materials and methods for data collection are described in detail elsewhere (26) . Briefly, the data included BP waveforms from the ascending aorta and femoral artery via micromanometer-tipped catheters and ECG waveforms, all at sampling rates of 500 Hz. For each subject, the data were obtained during a baseline period and two to four hemodynamic interventions out of a set of 12 different interventions (see Table 2 ).
Data Analysis
PAT and PTT estimation. We estimated PAT and PTT using the standard methods (16, 19, 22) . These methods approximate the time delays from the feet of the BP waveforms wherein wave reflection interference is minimal. More specifically, first, we automatically detected each foot of the BP waveforms as the intersection of a line tangent to the initial systolic rise and a horizontal line through the minimum point (5) . This automatic foot detection method was most effective among a set of conventional methods (e.g., peak of the derivative) (5). Then we visually examined many of the resulting foot detections and, in effect, manually corrected most, if not all, of the misdetections. Finally, we estimated PAT for each beat as the time delay between the ECG R-wave and the subsequent femoral artery BP foot and PTT for each beat as the time delay between the ascending aortic BP foot and the ensuing femoral artery BP foot.
PAT and PTT evaluation. We evaluated the beat-to-beat PAT and PTT estimates in terms of their ability to predict beat-to-beat BP (as averaging these quantities over multiple beats did not materially improve the results.) Figure 1 illustrates our evaluation procedure per subject. First, we determined diastolic BP (DBP), mean BP (MBP), and systolic BP (SBP) for each beat of the femoral artery BP waveforms. Second, we calibrated each of the time delays to each of the BP parameters using all of the time delay estimates and BP parameter measurements of the subject. In particular, we found the line that best fits these data and then mapped each time delay through the best fit line so as to predict the BP parameter. Third, we computed the root mean squared error [RMSE ϭ ͌(
), where and are the mean (bias) and standard deviation (precision) of the errors] between the predicted and measured BP parameters. Then, because velocity often shows better linear correlation to BP than time delay (8, 24), we repeated this procedure for 1/PAT and 1/PTT. Finally, while we focused on linear relationships, we also explored the effect of higher order polynomial relationships (see DISCUSSION) .
PAT and PTT comparison. We statistically compared the BP prediction ability of the time delays and their reciprocals. We employed straightforward one-way repeated-measures ANOVA to compare the subject average RMSE values after log transformation (for more normally distributed data). When this test yielded P Ͻ 0.05, we performed multiple pairwise comparisons using the Student-Newman-Keuls post hoc test. Table 1 summarizes the subject average results. The range of each BP parameter was wide, with SBP varying the most and DBP changing the least. For each BP parameter, 1/PTT and 1/PAT yielded a lower RMSE value than their nonreciprocal counterparts. However, none of these differences was significant. For PTT and 1/PTT, the DBP and MBP RMSE values were significantly lower than the SBP RMSE value by 1.7 to 2.7 mmHg. For PAT and 1/PAT, the three RMSE values were not significantly different. For each BP parameter, the RMSE values for PAT and 1/PAT were significantly higher than those for PTT and 1/PTT. The hike in RMSE obtained via PAT over PTT and via 1/PAT over 1/PTT ranged from 4.0 to 5.6 mmHg. The DBP RMSE value for 1/PAT, which was the lowest RMSE value attained via PAT, was 9.8 Ϯ 5.2 mmHg, whereas the corresponding value for 1/PTT was 5.3 Ϯ 1.2 mmHg. Table 2 shows the DBP RMSE values for 1/PTT and 1/PAT as well as the interventions employed for each subject, while Fig. 2 visually illustrates the correlation between DBP and the reciprocal of the time delays per subject. For each subject, 1/PAT was less effective in predicting DBP than 1/PTT. However, the extent of the difference was quite variable because of the intervention disparities. For subject 1, phenylephrine and nitroglycerin were infused. Figure 3 illustrates that vasoconstriction caused PTT to decrease due to the BP increase and PEP to increase due to the afterload increase. These opposite direction variations blunted the change in PAT. Thus the RMSE value for 1/PAT was over twice as large as for 1/PTT. For subjects 5 and 6, twice as many interventions were used compared with the other subjects. PEP was therefore more variable, and, as a result, the RMSE values for 1/PAT were again over twice as large as for 1/PTT. By contrast, for subjects 2 and 4, the DBP ranges were much narrower and thus constituted less of a challenge. Consequently, the RMSE values for 1/PAT were not that much higher than for 1/PTT. For subject 3, norepinephrine and xylazine were infused. These interventions caused PEP and PTT to change in the same direction. For example, norepinephrine caused PTT to decrease because of the increase in BP and PEP to decrease as the enhancement in cardiac contractility evidently dominated the increase in afterload. Thus the RMSE value for 1/PAT was again not considerably greater than for 1/PTT. Figure 4 illustrates the trends in DBP, 1/PAT, and 1/PTT from subject 6. In this subject, 1/PAT was less effective than 1/PTT in tracking the dynamic changes in DBP. However, note that even 1/PTT was ineffective during low rate cardiac pacing. During this intervention, 1/PTT predicted an increase in DBP, but DBP actually fell. In the remaining five subjects, 1/PAT and 1/PTT performed more similarly in terms of following directional DBP changes.
RESULTS
PTT 6.5 Ϯ 2.1 6.0 Ϯ 2.3 8.2 Ϯ 2.4 § 1/PTT 5.3 Ϯ 1.
DISCUSSION
In this study, we estimated PAT and PTT through the aorta using high-fidelity, invasive arterial waveforms obtained dur- ing multiple hemodynamic interventions in each of six animals that induced wide BP changes on average. We compared these time delays and their reciprocals in terms of their ability to predict DBP, MBP, and SBP via a linear relationship per subject. In contrast to similar studies in the past (see INTRODUCTION) , our results quantitatively indicate that PAT is not an adequate surrogate for PTT in terms of detecting challenging BP changes.
Time Delay vs. Reciprocal of Time Delay
Taking the reciprocals of the time delays tended to improve their ability to predict BP. This result is consistent with previous studies that have shown that velocity, rather than time delay, exhibits an excellent linear relationship with BP over a wide range (8, 24) . To confirm, we also investigated quadratic and cubic polynomial relationships including those in (7, 13) . We indeed found that use of the polynomial relationships tended to reduce the RMSE values much more for the time delays than for their reciprocals. For example, for a cubic polynomial relationship, the DBP RMSE values for PTT and 1/PTT were both 4.7 mmHg on average. So, the reciprocals of the time delays were essentially linearly related to the BP parameters here. The use of reciprocals may therefore offer greater simplicity for BP calibration.
DBP vs. MBP vs. SBP
PTT and its reciprocal predicted DBP and MBP significantly better than SBP. These results are consistent with previous experimental studies (18, 30) and theory. That is, PTT should be able predict DBP the best, because it is estimated from the waveform feet. Furthermore, PTT should also be able to predict MBP but not SBP, as only the former generally shows strong correlation with DBP. The difference in the DBP/MBP and SBP RMSE values was 2.2 mmHg on average. This difference can actually be more substantial. For example, we recently showed that the difference in the DBP and SBP RMSE values for 1/PTT was ϳ4.5 mmHg in conscious humans subjected to lower body negative pressure (30) . On the other hand, PAT and its reciprocal did not predict any of the BP parameters significantly better than the others. These results are in contrast to theory, which predicts that PAT should be able to predict DBP and MBP better than SBP for the same reasons as PTT, and previous experimental studies, which have paradoxically shown that PAT is most effective in predicting SBP (17, 24) . Thus PEP is a confounding factor.
PAT vs. PTT
PAT and its reciprocal were significantly inferior to PTT and its reciprocal in predicting all BP parameters. The RMSE values for PAT and 1/PAT ranged from 9.8 to 13.1 mmHg on average, whereas the corresponding values for PTT and 1/PTT varied from 4.8 to 8.2 mmHg. Furthermore, the RMSE values for PAT and 1/PAT were, on average, 78 Ϯ 23% higher than their PTT counterparts. Thus tracking BP via PAT was not only markedly worse than via PTT but also unable to meet the FDA bias and precision error limits of 5 and 8 mmHg (1a). These results are congruent with the conclusion of Geddes et al. (8) that PAT cannot be used in place of PTT.
For each subject, 1/PAT always tracked DBP less effectively than 1/PTT. However, the extent of the differences was variable and depended on the nature of the BP changes elicited in the subject. For example, consistent with the results of Steptoe et al. (25) , this difference was modest when the BP range was narrow. In general, the difference increased with the magnitude of BP change, degree of vasoconstriction, and number of interventions. Thus, in essence, the adequacy of PAT as a surrogate for PTT diminished as the BP changes became more challenging.
In one subject, 1/PAT was also noticeably less effective than 1/PTT in tracking the dynamic changes in BP. However, in the same subject, even 1/PTT was not useful in this capacity during low rate cardiac pacing. As heart rate fell, 1/PTT increased although BP declined. Indeed, the foot-to-foot detection technique can increasingly underestimate PTT with decreasing heart rate, because the extent of constructive interference of the reflected wave with the forward wave rises (17) . Although the FDA only considers the error of BP measurement devices, the omission of a rigorous assessment of the time delays and their reciprocals in terms of their ability to track dynamic BP changes constitutes a limitation of this study.
Waveform Foot Misdetections
We were able to accurately locate the waveform feet for PAT and PTT estimation by manual detection of invasive arterial waveforms with little artifact. However, in practice, the time delays would be estimated by automatic detection of the feet of noninvasive arterial waveforms with nontrivial artifact. Thus waveform foot misdetections are actually inevitable. Since accurate, automatic detection of the R-wave is feasible even when the ECG waveform is buried in artifact, PAT is less susceptible to misdetections. Thus, as indicated by the results of Payne et al. (20) , the difference in tracking BP via PAT and PTT may be closer in practice. However, BP tracking via both time delays would obviously become worse with misdetections.
BP Calibration
We tested the BP predicted via PAT and PTT against the same measured BP that was used to calibrate these time delays to BP. In practice, a BP calibration curve would first be constructed from simultaneous measurements of the time delays and peripheral BP during a hemodynamic perturbation and then future peripheral BP values would be predicted from only measurements of the time delay using the BP calibration curve. Thus we effectively employed the optimal BP calibration curves for both PAT and PTT to reveal (and fairly compare) their best case results. A realistic, suboptimal BP calibration curve would certainly further degrade the BP tracking ability of either time delay in practice.
Conclusion
In this study, PAT yielded BP errors that were ϳ80% larger than those for PTT. Furthermore, in contrast to PTT, the BP errors for PAT exceeded the FDA BP bias and precision error limits of 5 and 8 mmHg (1a). Thus PAT was not an adequate surrogate for PTT as a marker of BP despite the ideal circumstances of the study. Since significant, additional error will result in practice, further pursuit of PAT for continuous, noninvasive, and cuff-less BP monitoring may not be fruitful. However, further studies comparing PAT to PTT are still needed to draw an irrefutable conclusion. Other useful future research directions include the development of simpler sensors for measuring proximal arterial waveforms, convenient, patient-specific BP calibration curves, techniques for artifactrobust estimation of the true PTT in the absence of wave reflection (30) , and techniques for more accurately tracking SBP via PTT. 
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